TP53 and acute lymphoblastic leukemia: However, relapse remains a challenge in patients with TP53-disrupted r/r B-cell acute lymphoblastic leukemia (B-ALL) after receiving CAR19 T-cell therapy, even consolidated with allogeneic hematopoietic stem cell transplantation8,9.